|
CA2522411A1
|
|
Compositions and methods for cancer treatment
|
|
CA2540354A1
|
|
Nuclear receptor transcriptional corepressor and uses thereof
|
|
CA2471532A1
|
|
A synthetic chimeric fusion protein with immuno-therapeutic uses
|
|
CA2484050A1
|
|
Cultured stromal cells and uses thereof
|
|
EP1352078A1
|
|
Selectable marker for genetically engineered cells and tissues
|
|
CA2392941A1
|
|
Drug inducible system and use thereof
|
|
CA2321976A1
|
|
Retroviral vector for delivering a nucleotide sequence encoding a cellular gap junction protein
|
|
WO0114546A2
|
|
Replication protein a binding transcriptional factor (rbt1) and uses thereof
|
|
AU6676000A
|
|
Antineoplastic extract from achillea millefolium
|
|
EP1173551A2
|
|
Pseudotyped retroviral vector for gene therapy of cancer
|
|
EP1165098A2
|
|
Peroxovanadium compounds as antineoplastic agents for the treatment of cancer
|
